Published in J Immunol on February 15, 1987
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med (1987) 1.55
Complement regulation at the molecular level: the structure of decay-accelerating factor. Proc Natl Acad Sci U S A (2004) 1.17
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol (2007) 1.14
New structural motifs on the chymotrypsin fold and their potential roles in complement factor B. EMBO J (2000) 0.99
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation. Acta Crystallogr D Biol Crystallogr (2009) 0.85
Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B. Biochem J (1999) 0.85
Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B. Infect Immun (1994) 0.81
The principal site of glycation of human complement factor B. Biochem J (1991) 0.81
Murine monoclonal anti-Ba antibody that enhances haemolytic activity of factor B. Immunology (1991) 0.80
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J Cell Biol (1986) 8.65
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature (1984) 5.75
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity (2001) 4.92
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (1990) 4.67
B lymphocyte differentiation induced by lipopolysaccharide. I. Generation of cells synthesizing four major immunoglobulin classes. J Immunol (1975) 3.62
Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol (1987) 3.33
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol (2001) 3.08
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med (1984) 3.02
Developmentally controlled expression of immunoglobulin VH genes. Science (1985) 2.96
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol (1997) 2.77
Evidence that murine pre-B cells synthesise mu heavy chains but no light chains. Nature (1979) 2.74
IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol (1999) 2.73
High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques (1996) 2.63
B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol (2001) 2.57
B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev (2000) 2.55
A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol (1982) 2.41
Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice. Eur J Immunol (1981) 2.33
Anti-DNA autoantibodies in (NZB X NZW)F1 mice are clonally heterogeneous, but the majority share a common idiotype. J Immunol (1982) 2.25
Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity (2000) 2.23
Organization and expression of immunoglobulin genes in fetal liver hybridomas. Proc Natl Acad Sci U S A (1981) 2.23
Rabbit C1q: purification, functional and structural studies. J Immunol Methods (1972) 2.15
Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99
Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology (1999) 1.94
Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature (1983) 1.93
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
Adipsin and complement factor D activity: an immune-related defect in obesity. Science (1989) 1.87
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86
Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol (1997) 1.85
Polyketide synthase gene coupled to the peptide synthetase module involved in the biosynthesis of the cyclic heptapeptide microcystin. J Biochem (2000) 1.81
Distinct requirements for evoked and spontaneous release of neurotransmitter are revealed by mutations in the Drosophila gene neuronal-synaptobrevin. J Neurosci (1998) 1.80
The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology (2001) 1.79
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol (1982) 1.77
Complement activation by C-reactive protein complexes. Ann N Y Acad Sci (1982) 1.75
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature (1979) 1.75
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol (1974) 1.68
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol (1995) 1.61
Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun (1996) 1.60
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev (2000) 1.55
Pre-B cells: bone marrow persistence in anti-mu-suppressed mice, conversion to B lymphocytes, and recovery after destruction by cyclophosphamide. J Immunol (1978) 1.51
B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies. J Immunol (1976) 1.47
Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44
Allergy to laboratory animals: an epidemiological study. Br J Ind Med (1992) 1.44
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
Concentrations and isotope ratios of carbon, nitrogen and sulfur in ocean-floor basalts. Geochim Cosmochim Acta (1984) 1.42
Blood clearance of Streptococcus pneumoniae by C-reactive protein. J Immunol (1987) 1.42
Generation of immunoglobulin class diversity in b cells: a discussion with emphasis on idg development. Ann Immunol (Paris) (1976) 1.40
Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev (1986) 1.39
An embryonic source of Ly1 but not conventional B cells. Int Immunol (1991) 1.36
B cell differentiation induced by lipopolysaccharide. IV. Development of immunoglobulin class restriction in precursors of IgG-synthesizing cells. J Immunol (1976) 1.34
Human factor D of the alternative complement pathway: purification and characterization. J Immunol (1977) 1.33
Effects of anti-Ig antibodies on the development and differentiation of B cells. Immunol Rev (1980) 1.33
Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J Immunol Methods (1997) 1.32
B lymphocyte differentiation induced by lipopolysaccharide. II. Response of fetal lymphocytes. J Immunol (1975) 1.31
Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity (1999) 1.31
Isotype specificity of helper T cell clones. Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med (1984) 1.31
Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses. J Exp Med (1982) 1.30
Studies of generation of B-cell diversity in mouse, man, and chicken. Cold Spring Harb Symp Quant Biol (1977) 1.30
Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J Immunol (1997) 1.29
Differentiation of human B cells expressing the IgA subclasses as demonstrated by monoclonal hybridoma antibodies. J Immunol (1980) 1.29
Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A (1989) 1.29
Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim Biophys Acta (1997) 1.29
The human fetal omentum: a site of B cell generation. J Exp Med (1992) 1.28
B cell differentiation induced by lipopolysaccharide. V. Suppression of plasma cell maturation by anti-mu: mode of action and characteristics of suppressed cells. J Immunol (1978) 1.26
Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med (1998) 1.22
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol (1981) 1.22
Fine idiotype analysis of B cell precursors in the T-dependent and T-independent responses to alpha 1-3 dextran in BALB/c mice. J Exp Med (1983) 1.21
Inbreeding trends and pedigree analysis of Irish dairy and beef cattle populations. J Anim Sci (2006) 1.20
Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. Immunochemistry (1976) 1.20
Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med (1980) 1.19
Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system. Biochem J (1993) 1.19
C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res (1997) 1.18
Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol (1994) 1.17
Cloning of peroxisomal ascorbate peroxidase gene from barley and enhanced thermotolerance by overexpressing in Arabidopsis thaliana. Gene (2001) 1.17
Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J Mol Biol (1998) 1.16
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol (1992) 1.16
Selective effects of neuronal-synaptobrevin mutations on transmitter release evoked by sustained versus transient Ca2+ increases and by cAMP. J Neurosci (1999) 1.15
Functional characterization of monoclonal auto-anti-idiotype antibodies isolated from the early B cell repertoire of BALB/c mice. Eur J Immunol (1986) 1.15
The Arthus reaction in rodents: species-specific requirement of complement. J Immunol (2000) 1.14
Early rearrangements of genes encoding murine immunoglobulin kappa chains, unlike genes encoding heavy chains, use variable gene segments dispersed throughout the locus. Proc Natl Acad Sci U S A (1989) 1.14
Impact of nonadditive genetic effects in the estimation of breeding values for fertility and correlated traits. J Dairy Sci (2005) 1.13
Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity. Clin Exp Immunol (1978) 1.12
Studies on phosphorylcholine-specific T cell idiotypes and idiotype-specific immunity. Mol Immunol (1980) 1.12
On the structure of polymeric IgM. Eur J Immunol (1988) 1.11
Imputation of genotypes from low- to high-density genotyping platforms and implications for genomic selection. Animal (2011) 1.11
Human blood monocytes and platelets share a cell surface component. Blood (1982) 1.10
Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis (1989) 1.10
Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA. J Biol Chem (1990) 1.09
Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine. J Immunol (1986) 1.09
Immunoglobulin VH determinants defined by monoclonal antibodies. J Exp Med (1982) 1.09
Recombination activating genes-1 and -2 of the rabbit: cloning and characterization of germline and expressed genes. Mol Immunol (1993) 1.09
Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice. J Immunol (1999) 1.08
A role for human heavy chain binding protein in the developmental regulation of immunoglobin transport. Mol Immunol (1988) 1.08
Analysis of the anti-alpha 1 leads to 3 dextran response with monoclonal anti-idiotype antibodies. J Immunol (1983) 1.08
C-reactive protein binding specificities: artificial and natural phospholipid bilayers. Ann N Y Acad Sci (1982) 1.08